Zepbound vs Wegovy: which works better and which is easier to get online?

Short answer

• For average weight loss in clinical trials: tirzepatide (brand name Zepbound for weight) tends to produce larger mean weight loss than semaglutide (Wegovy).
• For ease of getting a prescription online right now: Wegovy/semaglutide has generally been easier to access through telehealth and obesity clinics; tirzepatide (Zepbound or Mounjaro) is spreading but is still somewhat more limited and often requires specialty clinics or more paperwork from insurers.

What the evidence says

• Zepbound = tirzepatide (Eli Lilly). In the tirzepatide obesity trials (SURMOUNT), average percent weight loss was larger (higher doses produced ~15–22% mean loss in trials) than what was seen in the semaglutide obesity trials (STEP; Wegovy), where mean loss was around ~15% in the best trials. That pattern has also held up in head-to-head comparisons in diabetes trials and aggregate evidence: tirzepatide gives greater average weight loss, though individual responses vary.
• Both drugs are GLP-1–based (tirzepatide is a dual GIP/GLP-1 agonist) and have similar side-effect profiles (nausea, vomiting, diarrhea, constipation). Tirzepatide can cause more GI upset at higher doses for some people. Both carry similar safety considerations (including warnings about thyroid C‑cell tumors in rodents and rare pancreatitis) — discuss with a clinician.

Practical availability online

• Wegovy (semaglutide 2.4 mg) has been prescribed widely by primary care and many telehealth weight-loss services. Many online clinics have semaglutide programs and experience managing the medication and side effects. That makes Wegovy generally easier to get via telehealth visits.
• Zepbound is newer as an obesity-labeled product, and access has been more limited initially. Clinicians have also prescribed Mounjaro (tirzepatide for type 2 diabetes) off-label for weight loss; some telehealth providers will prescribe Mounjaro more readily than Zepbound while insurers and supply catch up. Insurance approval and pharmacy supply can be more of a hurdle for tirzepatide for weight loss at present.

Where people commonly get them online (examples)

• Hims & Hers (Hers): offers semaglutide programs and telehealth follow-up; known for a structured program and convenient shipping.
• Ro (Ro.co): offers telehealth weight-loss services and has provided GLP‑1 prescriptions (semaglutide/tirzepatide depending on clinician assessment and availability).
• PlushCare: telehealth visits with primary-care physicians who can prescribe GLP‑1s when appropriate.
• Local obesity/weight-management clinics and endocrinologists: many now offer telehealth or hybrid care and help with insurance prior authorization for branded products.
  Note: availability and which exact brand/dose they will prescribe vary by provider, state regulations, and medical history.

Insurance, cost, and safety notes

• Insurance coverage varies widely. Both Wegovy and tirzepatide prescriptions may require prior authorization or be denied for the obesity indication; Mounjaro may be covered when used for diabetes but not for weight loss. Out-of-pocket cost without coverage can be high (often $1,000+ per month).
• Don’t buy from international or unverified pharmacies. Use licensed U.S. pharmacies or the pharmacy service associated with a reputable telehealth provider.
• You must be evaluated medically before starting (history, pregnancy/test status, pancreatitis, personal/family medullary thyroid carcinoma or MEN2, etc.). Close follow-up is important for titration and side-effect management.

Which should you pick?

• If your single goal is maximum average weight loss and you tolerate stronger GI effects and can navigate specialist access/insurance, tirzepatide/Zepbound tends to show greater weight loss in trials.
• If you want something that is currently easier to obtain via telehealth and has a longer track record for obesity programs, Wegovy/semaglutide is generally easier to access online and through primary-care telehealth programs.

If you want next steps

1. Talk to your primary care doctor or a reputable telehealth/weight clinic (examples above).
2. Ask about whether they prescribe Wegovy (semaglutide) or tirzepatide (Zepbound/Mounjaro) in your situation, coverage likelihood, and monitoring plan.
3. Don’t buy from unverified pharmacies; use the provider’s pharmacy or major national pharmacies.

If you want, tell me: your insurance status (private/Medicare/uninsured), whether you have diabetes, and how important absolute maximum weight loss is vs. convenience — I can suggest the best providers and likely routes for you.